Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The multicentre, open label, randomised phase III trial evaluated the NK1 antagonist aprepitant for the prevention of nausea and vomiting induced by oxaliplatin-based chemotherapy in Japanese patients with colorectal cancer
A total of 6,128 patients were included in the analysis, which showed that patients with the lowest BMI had a significantly shorter overall survival than patients in the other BMI categories
The ESMO President for the 2018-2019 period will be Josep Tabernero
The scale offers a rational, structured and consistent approach to ‘stratify’ a drug’s clinically meaningful benefit
To mark the European Week against Cancer, ESMO is highlighting positive developments and challenges to come from the EU's Clinical Trials Regulation
Circulating tumour DNA in blood a valid option for EGFR testing in patients who do not have accessible tumour tissue, study shows
Lack of test results may impact treatment effectiveness and survival, survey in Europe, Asia and US reveals
Survey shows that many live in ‘denial’ of the real risks of smoking even a small number of cigarettes a day
Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC
The award will be presented at the European Lung Cancer Conference (ELCC) 2015, held 15 to 18 April in Geneva, Switzerland
A course dedicated to educating the next generation of oncologists about the essentials of clinical trial design, implementation, and analysis, will be organised this week by ESMO
On World Cancer Day 2015, ESMO acknowledges patient’s right to access treatment and highlights collaborative efforts towards improving access for all
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
